🇺🇸 FDA
Patent

US 8524748

Heteroalkyl biphenyl antagonists of prostaglandin D2 receptors

granted A61KA61K31/41A61K31/433

Quick answer

US patent 8524748 (Heteroalkyl biphenyl antagonists of prostaglandin D2 receptors) held by Panmira Pharmaceuticals, LLC expires Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Panmira Pharmaceuticals, LLC
Grant date
Tue Sep 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/41, A61K31/433, A61K45/06, A61P